Skip to main content

Association between triglyceride glucose index and severity of diabetic foot ulcers in type 2 diabetes mellitus

Abstract

Background

Triglyceride glucose (TyG) index is a good surrogate biomarker to evaluate insulin resistance (IR). The study aimed to investigate whether the TyG index is related to the severity of diabetic foot ulcers (DFUs) in patients with type 2 diabetes mellitus (T2DM).

Methods

A total of 1059 T2DM patients were enrolled in this observational, retrospective, single-center study. TyG index was calculated as ln[fasting triglycerides (mg/dl) × fasting glucose (mg/ dl)/2]. The severity of DFUs was classified into mild-to-moderate DFUs (Wagner grade score < 3) and severe DFUs (Wagner grade score ≥ 3) based on Wagner classification. Patients were stratified according to the tertiles of TyG index. Logistic regression models were implemented to explore the association between TyG index and the severity of DFUs. Subgroup analyses were used to verify the reliability of results.

Results

Compared with the reference lowest TyG tertile (T1), the highest tertile (T3) was associated with 0.377-fold increased risk of prevalence of severe DFUs (odds ratio [OR] 1.377, 95% confidence interval [CI] 1.017–1.865) (P = 0.039). After adjusting for potential confounders, the multivariable-adjusted OR and 95% CI were 1.506 (1.079–2.103) (P = 0.016) in patients with highest tertile. Moreover, subgroup analyses indicated that the association was stronger among men, patients with age ≥ 65 years, duration of diabetes more than 10 years, or without PAD.

Conclusions

Elevated TyG index is independently associated with severity of DFUs even after adjusting conventional confounders.

Peer Review reports

Introduction

Diabetic foot ulcer (DFU), a severe complication with diabetes, usually occurs due to neuropathy and peripheral arterial disease (PAD) with a high global prevalence of 6.3% [1, 2]. Nearly 15% patients with diabetes were suffering a foot ulcer and the amputation rate of patients with diabetes is 15- to 40-fold higher compared to general population, contributing to a high rate of non-traumatic lower extremity amputations [3, 4]. Identifying patients at risk of lower extremity amputation and early intervention are a concern for clinicians.

Insulin resistance (IR) means that insulin exerts unsatisfactory biological effect in both experimental and clinical conditions. Previous studies have demonstrated that IR is one of the essential risk factors for cardiovascular disease [5], such as hypertension, vascular stiffness, as well as related to the progression of atherosclerosis [6, 7]. And it also can be closely associated with an advancing chronic kidney disease progress. [8, 9]. Hyperglycemia originated from IR in patients with diabetes are predisposed to developing chronic wounds such as DFUs. Because IR could delay wound healing though interplay among impaired tissue regeneration, vasculopathy, neuropathy and inflammation [10, 11].

Triglyceride glucose (TyG) index recently is used as a surrogate biomarker to evaluate IR due to it availability and inexpensiveness [12]. Hyperinsulinemic-euglycemic clamp (HIEC), as the gold standard to identify IR, however, was not put into practice as often because of its time-consuming and expensive [13]. And studies have shown that TyG index has a good correlation with IR assessed by HIEC and homeostasis model assessment of insulin resistance (HOMA-IR) [14, 15]. A reaseach conducted by Vasques, A.C., et showed that TyG index had a better perfomance in predicting insulin resistance than HOMA-IR in a Brazilian population. [16]

To the best of our knowledge, the correlation between TyG index and severity of DFU is still unclear. Therefore, in this study we aim to clarify the relationship between the severity of DFU and TyG index in Southeast of China.

Method

Study population

Two thousand one hundred fifty-eight patients with diabetic foot ulcer (DFU) were retrospectively enrolled at the First Affiliated Hospital of Wenzhou Medical University between January 2016 to December 2020. A total of 1100 patients were excluded due to following reasons: (a) patients were diagnosed with other types of diabetes mellitus, (b) patients were combined with other short-term life-threatening conditions, such as cancer, (c) medical records were incomplete or inaccurate (Fig. 1).

Fig. 1
figure 1

Flow chart of the study. T1DM, type 1 diabetes mellitus

Data collection and definitions

Data on eligible patients were retrospectively extracted from the electronic medical system. Characteristics at admission, including age, gender, smoking history, drinking history, and body mass index (BMI). Peripheral venous blood samples including hemoglobin (Hb), albumin (ALB), HbA1c, total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) were collected after overnight fasting (> 8 h) and measured in hospital laboratory department. Equation of modification of diet in renal disease (MDRD) [17] was used to calculate estimated glomerular filtration rate (eGFR). Bilateral lower extremity arteries including femoral artery, superficial femoral artery, popliteal artery, anterior tibial artery, posterior tibial artery, and dorsalis pedis artery of patients were examined by duplex ultrasonography and patients who had intima-media thickness, plaque occurrence, stenosis, and filling defects in blood flow was defined as PAD and diagnosed by qualified, experienced ultrasonic diagnostic experts [18]. The degree of severity of DFUs was subdivided according to the Wagner classification (grade score 0–5) and categorized as mild-to-moderate DFUs (Wagner grade score < 3) and severe DFUs (Wagner grade score ≥ 3) [19]. The TyG index was calculated as ln[fasting triglycerides (mg/dl) × fasting glucose (mg/ dl)/2].

Data analysis

Data normality was tested by Kolmogorov–Smirnov test. Continuous variables, described as mean ± standard deviation or median (interquartile range), were compared using by one-way analysis of variance (ANOVA) or Kruskal Wallis. And categorical variables, expressed as number (percentage), were compared using Chi-squared test or Mantel–Haenszel χ2 test. To estimate the association between TyG quartiles and Wagner classification(Wagner < 3 versus Wagner ≥ 3), logistic regression models were employed calculate odds ratios (ORs) and 95% confidence interval (CI). Finally, four multivariable regression models were constructed. Model 1 was not adjusted. Model 2 was adjusted for age, and gender. Model 3 was adjusted for variables included in Model 2 and BMI, smoking, alcohol, PAD, duration of diabetes ≥ 10 years. Model 4 was adjusted for variables included in Model 3 and Hb, ALB, HbA1c, eGFR, TC, LDL-C, HDL-C. Subgroup analyses were implemented to further verify the robustness of the results. What’s more, the interaction between subgroups was conducted to assess the interaction among subgroups. All statistical analyses were performed using SPSS for Windows version 22, and a two-sided P < 0.05 was considered as significant.

Results

Baseline characteristics

The clinical characteristics of the study population were stratified into three groups according to their TyG index levels (tertile 1: ≤ 7.28, tertile 2: 7.28 ~ 7.90, tertile 3: > 7.90). The baseline characteristics of the study population were shown in Table 1. Significant difference was observed in patients with PAD (P = 0.004). Among the 1059 patients, 756 patients had PAD as described above while the rest was normal in the lower limb arteries. Further Significant difference was also observed high score DFUs (P = 0.039). The highest tertile tended to have higher Alb (P < 0.001) and lower eGFR (P < 0.001). Furthermore, higher levels of HbA1c, TC, LDL-C were seen in the highest tertile.

Table 1 Clinical characteristics according to the TyG tertiles

Logistic regression analysis between TyG index and severity of DFUs

The multivariable logistic analysis was performed to explore the relationship between TyG tertile and severity of DFUs (Table 2). Comparing with tertile 1 as reference, the tertile 3 was related to the presence of high score DFUs in the unadjusted model (OR = 1.377 [95% CI: 1.017–1.865], P = 0.039). Furthermore, the significant difference of this association still existed in the fully adjusted model (OR = 1.506 [95% CI: 1.079–2.103], P = 0.016).

Table 2 The relationship between TyG index and the severity of DFUs

Subgroup analysis on association between TyG index and severity of DFUs

To further investigate the impact of other risk factors on the association of TyG index with severity of DFUs, subgroup analyses were carried on according to the following stratification variables: age, sex, BMI, smoking, drinking and PAD. The results of subgroup analyses and interactions were summarized in Table 3. No additional interaction was observed between TyG index and severity of DFUs. More pronounced effects were found among men, patients with age ≥ 65 years, duration of diabetes more than 10 years, or without PAD.

Table 3 Subgroup analysis of the association between the TyG and DFUs

Discussion

In this study, we retrospectively investigated the relationship between the TyG index and severity of DFUs in Southeast of China and revealed that the TyG index was significantly associated with the Wagner classification, independent of conventional diabetic foot risk factors, including age, gender, BMI, smoking, alcohol, PAD, duration of diabetes ≥ 10 years, HB, ALB, HbA1c, eGFR, TC, LDL-C, HDL-C. Similar results were found in the subgroup analysis, further emphasizing the robustness of these associations. To our best knowledge, the present study is the first study to explore the relationship between the TyG index and the severity of DFUs.

TyG index is a simple surrogate for IR, which has been implicated as a factor in cardiovascular disease [20,21,22,23]. Accumulating retrospective studies have indicated that high TyG index levels seemed to be associated with an increased risk of major adverse cardiovascular events (MACEs) [24,25,26,27]. Moreover, recent data showed that higher TyG index reflected a more severe IR and was associated with poor outcomes due to all-cause and cardiovascular disease in a non-linear manner [28,29,30], suggesting that insulin resistance plays a promoting role in the pathogenesis of cardiovascular and metabolic diseases [31]. Furthermore, Zhao, S., et al. [32] reported that an elevated TyG index was significantly related to a higher risk of both marco- and microvascular damage. This conclusion is in favor of the clinical importance of the TyG index in assessing peripheral vascular injury.

In the last years, the prevalence of PAD has been reported approximately in 65–70% of patients with ischaemic DFUs being a current issue for professionals involved in the management of diabetic foot disease [33]. Previous studies have reported the relationship between TyG index and PAD, which is one of pathogenesis of diabetic foot. A study of a small retrospective study of 71 participants showed that TyG index was an independent biomarker of PAD [34]. Moreover Gao, J.W., et al. demonstrated that Higher TyG index is independently associated with an increased risk of incident PAD based on a large sample size of 12,320 PAD patients [35]. However, they draw a conclusion in their study based on a non-diabetic patient population. While in our study, we indeed found that higher TyG index was correlated to higher Wagner classification, which referred to the presence of more severe diabetic foot ulcers. Interestingly, no significant difference was observed in PAD in the logistic regression models. This can be attributed to failure to adjust the mild PAD that may not influence the lower extremity blood flow because we didn’t stratify the severity of PAD.

Subgroup analysis and exploration of interactions is critical for clinical research, to better understand the actual relationships between independent variables and dependent variables. In this study, these factors, including age, sex, BMI, smoking, drinking, PAD and duration of diabetes, were taken as stratified variables, and more pronounced effects were observed in participants with age ≥ 65 years, duration of diabetes more than 10 years, or in males, or without PAD. The results demonstrated that patients who were elder and had longer duration of diabetes were more predisposed to develop more severe diabetic foot ulcers. A prospective cohort study conducted by Chu, Y.J., et al. reported that those who were more than 70 years were considered as an independent predictor of re-amputation, mortality and functional decline in daily life [36]. The results of our study found the severity of PAD did not interact with the association between TyG and severity of DFUs significantly, although more pronounced effect of TyG on DFUs can be observed in patients without PAD. We hypothesize that there were more confounding factors in patients with PAD, such as more complications, interventions, and utilization of drugs related to hyperlipidemia, hypertension, and antiplatelet, which would attenuate the relationship between TyG and severity of DFUs in PAD subgroup. The current studies suggested that diabetic foot and amputation prevention strategies should focus on men, working freelancers and those with long-term diabetes [37,38,39]. Increasing knowledge with regard to diabetic foot would help avoid further complications and reduce the occurrence of DFUs. On the whole, based on subgroup analysis, the TyG index appeared to be more sensitive for predicting risk of diabetic foot ulcer in elder male individuals, suggesting it may be promising for screening risk of future diabetic foot ulcers, Therefore, systematic and individualized education should be provided to improve the self-care practice related to diabetic foot prevention in patients with diabetes to avoid further poor outcome.

The strength of this study is that we use an available and inexpensive biomarker to explore the relationship between TyG index and the severity of diabetic foot ulcers based on large populations. Nonetheless, this study also has some limitations. First, this study is a retrospective cross-sectional observational study. Given that TyG index levels may vary over time, the dynamic TyG index should be measured in the following clinical work. What’s more, due to the cross-sectional study, we could not determine the causal relationship between TyG level changes and PAD occurrence. And we provide a reasonable hypothesis that most PAD patients administered hypolipidemic or antiplatelet agents to manage of lipid levels to prevent further advancement of arteriosclerosis. These two factors may lead to the higher lever in TyG Tertile1 and no interaction between PAD subgroup. Second, HIEC, the gold standard method for measuring IR, was not used to compare with the TyG index. However, a large number of studies mentioned above have demonstrated the relationship between the TyG index and IR, as measured by the HIEC. Third, other confounding factors such as exercise habit, nutritional status and medication were not included in the model. Fourth, limitation of sample size may account for no significant difference in the interaction between TyG and other variables.

Conclusion

In conclusion, we found higher triglyceride glucose index is independently associated with severity of diabetic foot ulcers in individuals with diabetes even after adjusting for conventional risk factors. In this instance, TyG index may serve as a helpful tool in the assessment of DFUs. Furthermore, the potential mechanism of the relationship between the TyG index and the severity of DFUs requires further prospective large-scale exploration.

Availability of data and materials

The datasets analyzed during the current study are available from the corresponding author upon reasonable request, provided appropriate credit is attributed to the original authors and the data source.

References

  1. Zhang P, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med. 2017;49(2):106–16.

    Article  PubMed  Google Scholar 

  2. Rastogi A, et al. Long term outcomes after incident diabetic foot ulcer: Multicenter large cohort prospective study (EDI-FOCUS investigators) epidemiology of diabetic foot complications study: Epidemiology of diabetic foot complications study. Diabetes Res Clin Pract. 2020;162:108113.

    Article  PubMed  Google Scholar 

  3. Umashankar GT, Kumar A, Shahid M. Predictors of lower extremity amputation in patients with diabetic foot ulcer. Int Surg J. 2019;6(4):1208–13.

    Article  Google Scholar 

  4. Gazzaruso C, et al. Predictors of healing, ulcer recurrence and persistence, amputation and mortality in type 2 diabetic patients with diabetic foot: a 10-year retrospective cohort study. Endocrine. 2021;71(1):59–68.

    Article  CAS  PubMed  Google Scholar 

  5. Ormazabal V, et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hill MA, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.

    Article  CAS  PubMed  Google Scholar 

  7. Lee SB, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 2018;17(1):41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Chen J, Muntner P, et al. The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults. Ann Intern Med. 2004;140:167–74.

    Article  PubMed  Google Scholar 

  9. Kubo M, et al. Effect of hyperinsulinemia on renal function in a general Japanese population: The Hisayama study. Kidney Int. 1999;55:2450–6.

    Article  CAS  PubMed  Google Scholar 

  10. Haba D, et al. Low-frequency vibration promotes AMPK-mediated glucose uptake in 3T3-L1 adipocytes. Heliyon. 2021;7(9):e07897.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Bashmakov YK, Assaad-Khalil S, Petyaev IM. Resveratrol may be beneficial in treatment of diabetic foot syndrome. Med Hypotheses. 2011;77(3):364–7.

    Article  CAS  PubMed  Google Scholar 

  12. Ramdas Nayak VK, et al. Triglyceride Glucose (TyG) Index: a surrogate biomarker of insulin resistance. J Pak Med Assoc. 2022;72(5):986–8.

    Article  PubMed  Google Scholar 

  13. Ding X, et al. Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies. Cardiovasc Diabetol. 2021;20(1):76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.

    Article  CAS  PubMed  Google Scholar 

  15. Guerrero-Romero F, et al. The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.

    Article  CAS  PubMed  Google Scholar 

  16. Vasques AC, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–100.

    Article  CAS  PubMed  Google Scholar 

  17. Andrew S, Levey M, et al. A More accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461–70.

    Article  Google Scholar 

  18. Hong J, et al. Association between heart rate-corrected QT interval and severe peripheral arterial disease in patients with type 2 diabetes and foot ulcers. Endocr Connect. 2021;10(8):845–51.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Hong J, et al. Free Triiodothyronine and free Triiodothyronine to Free Thyroxine Ratio Predict all-cause mortality in patients with diabetic foot ulcers. Diabetes Metab Syndr Obes. 2022;15:467–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Zhao Q, et al. Triglyceride-glucose index as a surrogate marker of insulin resistance for predicting cardiovascular outcomes in Nondiabetic patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. J Atheroscler Thromb. 2021;28(11):1175–94.

    Article  CAS  PubMed  Google Scholar 

  21. Yoon JS, et al. Triglyceride glucose index is superior biomarker for predicting type 2 diabetes mellitus in children and adolescents. Endocr J. 2022;69(5):559–65.

    Article  CAS  PubMed  Google Scholar 

  22. Wang X, et al. Association between the triglyceride-glucose index and severity of coronary artery disease. Cardiovasc Diabetol. 2022;21(1):168.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Ferreira JRS, et al. Insulin resistance by the triglyceride-glucose index in a rural Brazilian population. Arch Endocrinol Metab. 2022;66(6):848–55.

    PubMed  PubMed Central  Google Scholar 

  24. Zhang Y, et al. High triglyceride-glucose index is associated with adverse cardiovascular outcomes in patients with acute myocardial infarction. Nutr Metab Cardiovasc Dis. 2020;30(12):2351–62.

    Article  CAS  PubMed  Google Scholar 

  25. Zhao ZW, et al. Triglyceride-glucose index and non-culprit coronary plaque characteristics assessed by optical coherence tomography in patients following acute coronary syndrome: a cross-sectional study. Front Cardiovasc Med. 2022;9:1019233.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Zhao X, et al. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study. Cardiovasc Diabetol. 2021;20(1):131.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Zhao Q, et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):108.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Liu XC, et al. The Triglyceride-Glucose Index, an Insulin Resistance Marker, Was Non-linear Associated With All-Cause and Cardiovascular Mortality in the General Population. Front Cardiovasc Med. 2020;7:628109.

    Article  CAS  PubMed  Google Scholar 

  29. Yu Y, et al. Combined association of triglyceride-glucose index and systolic blood pressure with all-cause and cardiovascular mortality among the general population. J Transl Med. 2022;20(1):478.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Zhang Y, et al. High Triglyceride-Glucose Index is Associated with Poor Cardiovascular Outcomes in Nondiabetic Patients with ACS with LDL-C below 1.8 mmol/L. J Atheroscler Thromb. 2022;29(2):268–81.

    Article  CAS  PubMed  Google Scholar 

  31. Lopez-Jaramillo P, et al. Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study. Lancet Healthy Longev. 2022;4:e23–e33.

  32. Zhao S, et al. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study. Cardiovasc Diabetol. 2019;18(1):95.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Meloni M, et al. Foot revascularization avoids major amputation in persons with diabetes and ischaemic foot ulcers. J Clin Med. 2021;10(17):3977.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Duran Karaduman B, et al. The triglyceride-glucose index predicts peripheral artery disease complexity. Turk J Med Sci. 2020;50(5):1217–22.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Gao JW, et al. Triglyceride-glucose index in the development of peripheral artery disease: findings from the Atherosclerosis Risk in Communities (ARIC) Study. Cardiovasc Diabetol. 2021;20(1):126.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Chu YJ, et al. Clinical outcomes of toe amputation in patients with type 2 diabetes in Tianjin. China Int Wound J. 2016;13(2):175–81.

    Article  PubMed  Google Scholar 

  37. Hanley G, et al. Foot care knowledge, attitudes and practices among patients with diabetic foot and amputation in St. Kitts and Nevis. Int Wound J. 2020;17(5):1142–52.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Jia H, Wang X, Cheng J. Knowledge, attitudes, and practices associated with diabetic foot prevention among rural adults with diabetes in North China. Front Public Health. 2022;10:876105.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Tuglo LS, et al. Knowledge and practice of diabetic foot care and the prevalence of diabetic foot ulcers among diabetic patients of selected hospitals in the Volta Region. Ghana Int Wound J. 2022;19(3):601–14.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We are very grateful to the staff and participants included in this cohort study.

Funding

Zhejiang Wound Repair and Transformation Application project (ZJ2021-LD002), Wenzhou Science and Technology Bureau Project of China (Y2020236), Natural Science Foundation of Zhejiang Province of China (LGD22H070001).

Author information

Authors and Affiliations

Authors

Contributions

WHC: design, analysis, writing. XDW: data collection, design, writing. QLJ: data collection, revise. JYW:data collection, revise. WYS: comment, revise. XXW: draw, data collection. YHY: data collection, JYZ: technical support. XH: conceptualization, supervision, CL:conceptualization, supervision, XXZ: writing-review and editing. All authors read and approved the fnal manuscript. All authors read, amended, and approved the fnal manuscript.

Corresponding authors

Correspondence to Xiang Hu, Cai Lin or Xingxing Zhang.

Ethics declarations

Ethics approval and consent to participate

This study was approved by the clinical research ethics committee of The First Affiliated Hospital of Wenzhou Medical University (acceptance number: KY2021-R132), which was the main study site and the institution where the data were collected.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, W., Wang, X., Jiang, Q. et al. Association between triglyceride glucose index and severity of diabetic foot ulcers in type 2 diabetes mellitus. J Foot Ankle Res 16, 68 (2023). https://doi.org/10.1186/s13047-023-00663-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13047-023-00663-7

Keywords